Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Anti-Müllerian Hormone in PCOS: A Review Informing International Guidelines.

Teede H, Misso M, Tassone EC, Dewailly D, Ng EH, Azziz R, Norman RJ, Andersen M, Franks S, Hoeger K, Hutchison S, Oberfield S, Shah D, Hohmann F, Ottey S, Dabadghao P, Laven JSE.

Trends Endocrinol Metab. 2019 Jul;30(7):467-478. doi: 10.1016/j.tem.2019.04.006. Epub 2019 May 31. Review.

PMID:
31160167
2.

Lifestyle changes in women with polycystic ovary syndrome.

Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ.

Cochrane Database Syst Rev. 2019 Mar 28;3:CD007506. doi: 10.1002/14651858.CD007506.pub4.

PMID:
30921477
3.

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.

Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ; International PCOS Network.

Hum Reprod. 2018 Sep 1;33(9):1602-1618. doi: 10.1093/humrep/dey256. Erratum in: Hum Reprod. 2019 Feb 1;34(2):388.

4.

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.

Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ; International PCOS Network.

Fertil Steril. 2018 Aug;110(3):364-379. doi: 10.1016/j.fertnstert.2018.05.004. Epub 2018 Jul 19. Review.

5.

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.

Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ; International PCOS Network.

Clin Endocrinol (Oxf). 2018 Sep;89(3):251-268. doi: 10.1111/cen.13795. Epub 2018 Jul 19.

PMID:
30024653
6.
7.

Associations of Vitamin D with Inter- and Intra-Muscular Adipose Tissue and Insulin Resistance in Women with and without Polycystic Ovary Syndrome.

Scott D, Joham A, Teede H, Gibson-Helm M, Harrison C, Cassar S, Hutchison S, Ebeling PR, Stepto N, de Courten B.

Nutrients. 2016 Nov 30;8(12). pii: E774.

8.

Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.

Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ.

Hum Reprod. 2013 Mar;28(3):777-84. doi: 10.1093/humrep/des463. Epub 2013 Jan 12.

PMID:
23315061
9.

Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training.

Joham AE, Teede HJ, Hutchison SK, Stepto NK, Harrison CL, Strauss BJ, Paul E, Watt MJ.

Obesity (Silver Spring). 2012 Dec;20(12):2390-6. doi: 10.1038/oby.2012.135. Epub 2012 May 29.

10.

Lifestyle changes in women with polycystic ovary syndrome.

Moran LJ, Hutchison SK, Norman RJ, Teede HJ.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD007506. doi: 10.1002/14651858.CD007506.pub3. Review. Update in: Cochrane Database Syst Rev. 2019 Mar 28;3:CD007506.

PMID:
21735412
11.

The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.

Harrison CL, Stepto NK, Hutchison SK, Teede HJ.

Clin Endocrinol (Oxf). 2012 Mar;76(3):351-7. doi: 10.1111/j.1365-2265.2011.04160.x.

PMID:
21711376
12.

Lifestyle changes in women with polycystic ovary syndrome.

Moran LJ, Hutchison SK, Norman RJ, Teede HJ.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007506. doi: 10.1002/14651858.CD007506.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD007506.

PMID:
21328294
13.

Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.

Hutchison SK, Stepto NK, Harrison CL, Moran LJ, Strauss BJ, Teede HJ.

J Clin Endocrinol Metab. 2011 Jan;96(1):E48-56. doi: 10.1210/jc.2010-0828. Epub 2010 Oct 6.

PMID:
20926534
14.

Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.

Teede HJ, Meyer C, Hutchison SK, Zoungas S, McGrath BP, Moran LJ.

Fertil Steril. 2010 Jan;93(1):184-91. doi: 10.1016/j.fertnstert.2008.09.034. Epub 2008 Nov 18.

PMID:
19019358
15.

A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.

Moran LJ, Hutchison SK, Meyer C, Zoungas S, Teede HJ.

Clin Sci (Lond). 2009 May;116(10):761-70. doi: 10.1042/CS20080218.

PMID:
18851710
16.

Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome.

Hutchison SK, Harrison C, Stepto N, Meyer C, Teede HJ.

Diabetes Care. 2008 Jul;31(7):1427-32. doi: 10.2337/dc07-2265. Epub 2008 Apr 4.

17.

The management of insulin resistance in polycystic ovary syndrome.

Teede HJ, Hutchison SK, Zoungas S.

Trends Endocrinol Metab. 2007 Sep;18(7):273-9. Epub 2007 Aug 16. Review.

PMID:
17698366
18.

Insulin levels, insulin resistance and the use of metformin in polycystic ovary syndrome.

Hutchison SK, Zoungas S, Teede HJ.

Med J Aust. 2007 Mar 5;186(5):268-9; author reply 271-2. No abstract available.

PMID:
17391092

Supplemental Content

Loading ...
Support Center